CRL shareholders approve 2026 LTIP, re-elect all 12 directors

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

2026 Long-Term Incentive Plan approved with 41.5M for vs 2.6M against; 4.825M shares authorized.
All 12 director nominees elected; Abraham Ceesay received highest withhold (8.3M against).
Advisory say-on-pay passed with 41.4M for vs 2.7M against, 1.7M broker non-votes.
Ratification of PricewaterhouseCoopers as auditor approved with 43.6M for vs 2.2M against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent auditors for fiscal 2026.

Proposal: auditor ratification
Outcome: passed

Exact text from the filing

(d) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2026.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Approval of the 2026 Long-Term Incentive Plan.

Proposal: equity plan
Outcome: passed

Exact text from the filing

(c) The shareholders approved the 2026 Long-Term Incentive Plan.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Election of twelve directors.

Proposal: director election
Outcome: passed

Exact text from the filing

(a) The following twelve (12) directors were elected to serve until our 2027 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Advisory vote on named executive officer compensation.

Proposal: say on pay
Outcome: passed

Exact text from the filing

(b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers.

View on SEC.gov

461 shareholder votes filed in the last 30 days. Browse all shareholder votes →

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0000950103-26-007060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.